A new report says tablets have created a range of new opportunities for pharmaceutical companies as almost two-thirds of doctors and physicians in the U.S. are now using tablets (most of them iPads).
Research and Markets says that every major biopharmaceutical company has developed iPad apps. The apps cover the entire range of activities from helping incontinent patients find a public toilet and educating doctors on drugs to reading electronic medical and health records.
In the pharmaceutical and healthcare industry, tablets have been deployed across a range of use cases, including sales representatives using them in their interaction with physicians, to research labs and production processes.
In addition to the two-thirds of doctors and physicians already already using tablets, Research and Markets says 70% of of non-users in the U.S. plan to buy a tablet in the next year.
“This creates a huge market for pharma firms to leverage the iPad infrastructure as a customer's sales and education tool,” says Research and Markets, which just released a new report entitled “iPad and Smartphone Use in the Pharma Market”.